Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Nanotherapeutics Inc patents

Recent patent applications related to Nanotherapeutics Inc. Nanotherapeutics Inc is listed as an Agent/Assignee. Note: Nanotherapeutics Inc may have other listings under different names/spellings. We're not affiliated with Nanotherapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Nanotherapeutics Inc-related inventors

Novel influenza virus

The present invention provides a novel influenza virus wherein both the NS and the PB1 gene segments are modified and wherein the PB1-F2 open reading frame is modified by introduction of at least one stop codon. Specifically, the influenza virus is lacking functional NS1 and PB1-F2 proteins. Additionally, a vaccine... Nanotherapeutics Inc

Compositions and methods for delivery of poorly soluble drugs

Described herein are compositions comprising particles of poorly soluble drugs encapsulated by stabilizers. Further described are pharmaceutical compositions comprising such encapsulated compositions. Also described are methods of making such encapsulated particle compositions, and methods of making the corresponding pharmaceutical compositions. The encapsulated particle compositions described herein allow poorly soluble drugs... Nanotherapeutics Inc

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses

The present invention relates to recombinant viral vectors and methods of using the recombinant viral vectors to induce an immune response to influenza A viruses. The invention provides recombinant viral vectors based, for example, on the non-replicating modified vaccinia virus Ankara. When administered according to methods of the invention, the... Nanotherapeutics Inc

Enveloped virus vaccine and production

... Nanotherapeutics Inc

Methods of treatment of c. difficile spores with ramoplanin

The present disclosure relates generally to methods of treatment of Clostridium difficile-associated disorders and/or C. difficile spores in the gastrointestinal tract by administering ramoplanin or a pharmaceutical formulation thereof, pharmaceutical compositions comprising ramoplanin, and therapeutic uses thereof in treating Clostridium difficile-associated disorders and/or C. difficile spores.... Nanotherapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Nanotherapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nanotherapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by